Vendor, Newark, CA, part of Dna Twopointo Inc.
Dna Twopointo Inc.
UEI G9S3SC8T5DM1, CAGE 3ENW7
1 award and $75,000 obligated between July 20, 2026 and July 20, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $75,000 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023P00594Purchase Order, July 20, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Yearly License (Maintenance Fee and Ind Filing Fee) to Use a Monoclonal Antibody Produced Via Atum Proprietary Cell Line TechnologyNAICS 325414, PSC 6505 | $75,000 |
- Places of performance
- California
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards